Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Henoch-Schönlein purpura.

F T Saulsbury1

  • 1Division of Immunology and Rheumatology, Department of Pediatrics, University of Virginia Health System, Charlottesville, Virginia 22908, USA. fts@virginia.edu

Current Opinion in Rheumatology
|January 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel mutation in TNFRSF1A associated with overlapping features of tumor necrosis factor receptor-associated periodic syndrome and hyper-IgD syndrome.

Clinical and experimental rheumatology·2010
Same author

Acquired Brown's syndrome in a child with poststreptococcal reactive arthritis.

The Journal of rheumatology·2002
Same author

Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same author

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Nature genetics·2001
Same author

Crohn's disease presenting with Henoch-Schönlein purpura.

Journal of pediatric gastroenterology and nutrition·2000
Same author

Hypocomplementemic urticarial vasculitis: report of a pediatric case.

Pediatric nephrology (Berlin, Germany)·2000
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Henoch-Schönlein purpura (HSP), a common childhood vasculitis, is increasingly understood through immunoglobulin A1 glycosylation abnormalities. Aberrant glycosylation of this protein plays a key role in HSP

Area of Science:

  • Pediatrics
  • Immunology
  • Rheumatology

Background:

  • Henoch-Schönlein purpura (HSP) is the most frequent vasculitis affecting children.
  • While clinical features and diagnosis are established, etiology and treatment remain incompletely understood.
  • Recent research highlights a gap in understanding HSP pathogenesis.

Purpose of the Study:

  • To review the clinical aspects of Henoch-Schönlein purpura (HSP).
  • To present new information regarding HSP therapy.
  • To focus on the role of immunoglobulin A1 (IgA1) glycosylation in HSP pathogenesis.

Main Methods:

  • Literature review of clinical aspects of HSP.
  • Review of recent therapeutic advancements for HSP.
  • Focus on recent findings regarding immunoglobulin A1 (IgA1) glycosylation abnormalities.

Related Experiment Videos

Main Results:

  • HSP is primarily a pediatric disease, with well-documented clinical features.
  • Significant gaps persist in understanding HSP etiology, pathogenesis, and treatment.
  • Aberrantly glycosylated IgA1 is implicated in the pathogenesis of HSP.

Conclusions:

  • HSP is the most common vasculitis in children.
  • Understanding IgA1 glycosylation abnormalities offers new insights into HSP pathogenesis.
  • Further research into IgA1 glycosylation may guide future HSP therapies.